Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?

NCT00206986 is registered in ClinicalTrials.gov with Birte Glenthoj as lead sponsor.

NCT NCT00206986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00206986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?
Lead sponsor
Birte Glenthoj
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2005
Completion date
December 31, 2011
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia